Testing for Primary HIV Infection in Seronegative Patients

The summary for the Testing for Primary HIV Infection in Seronegative Patients grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Testing for Primary HIV Infection in Seronegative Patients: The purpose of the program is to determine the feasibility, effectiveness, and costs of screening for acute infection among seronegative individuals tested for HIV. The research objectives of the program are as follows: 1. To compare different tests and testing algorithms that could be used to detect acute infection (nucleic acid testing, p24 antigen testing, third-generation EIA, OraQuick, alterations in current diagnostic algorithm) where possible with regard to feasibility, sensitivity, specificity, predictive value, and cost. 2. To determine optimal settings/venues and/or individuals to be screened with a test sensitive for PHI. 3. To collect a panel of longitudinal specimens from a cohort of recently infected individuals. 4. To obtain preliminary information on alternative pooling strategies for nucleic acid testing to optimize cost and predictive value of test results. The estimated funding date is September 1, 2004.
Federal Grant Title: Testing for Primary HIV Infection in Seronegative Patients
Federal Agency Name: Centers for Disease Control and Prevention
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: CDC-PA04119
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.943
CFDA Descriptions: Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in Selected Population Groups
Current Application Deadline: No deadline provided
Original Application Deadline: Jul 23, 2004 Applications must be received in the
Posted Date: May 26, 2004
Creation Date: Aug 22, 2004
Archive Date: Aug 22, 2004
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 30
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility
Applicants for Part 1 must demonstrate their ability to provide, in a 12 month period, samples from 50,000 seronegative individuals. Applicants for Part 2 must demonstrate experience using automated methods for conducting pooled nucleic acid testing, the ability to return results within 7 calendar days, and the ability to process 8,000-10,000 specimens per month for the required testing.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
(TIMS), Technical Information Management Section, Point of Contact, Phone 770-488-2700, Email pgotim@cdc.gov pgotim@cdc.gov (TIMS), Technical Information Management Section
Similar Government Grants
Centers for Disease Control and Prevention Cooperative Re-Engagement Controlled Trial (CoR...
The Cooperative Re-Engagement Controlled Trial (CoRECT)
Opportunity RFA-PS-11-003
Screening Targeted Populations to Interrupt On-going Chains of Transmission with Enhanced ...
Minority HIV/AIDS Research Initiative to Build Capacity in Black and Hispanic Communities ...
Rapid Strengthening of Blood Transfusion Services in Selected Countries in Africa and the ...
Providing Techincal Assistance for the Rapid Strengthening of Blood Transfusion Services i...
Capacity Building Assistance to Improve the Delivery and Effectiveness of Human Immunodefi...
More Grants from the Centers for Disease Control and Prevention
93.067
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
Strengthening Ebola rapid detection and response capacity through community based surveill...
test2

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com